Tone mix
Week by week 51 weeks
Share of NovoCure Limited Ordinary Shares's 150 headlines over the last 52 weeks by the model's call, and the same mix week by week.
Biggest swings in the last year
The weeks whose tone moved furthest from the 8-week average, with the story most outlets carried that week.
- Week of Sep 7, 2026 · tone -77Novocure Reports Patient Data Exposure in Cybersecurity Incident-104
- Week of Aug 11, 2025 · tone +100Leerink Partners Reiterates a Buy Rating on NovoCure Limited (NVCR)+86
- Week of Jul 28, 2025 · tone -66Why NovoCure Stock Is Cratering Today-80
- Week of Aug 31, 2026 · tone -46Oncology firm Novocure says cyberattack exposed US patient records-71
- Week of Sep 29, 2025 · tone 0Novocure to Report Third Quarter 2025 Financial Results-68
- Week of Feb 2, 2026 · tone -50NovoCure billing privileges revoked by Medicare (NVCR:NASDAQ)-67
Daily headline tone, last 90 sessions
Hover a session for its totals; click to pin.
Each point is the average score of the headlines about NovoCure Limited Ordinary Shares in one trading session, with the 8-session average drawn through it. Sessions with no headline about the company have no point.
Tone by period
Show the table · 3 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Last 7 sessions | 2 | +98 |
| Last 30 sessions | 7 | +28 |
| Last 90 sessions | 44 | +20 |
No matching rows. Clear the filter to see all records.
Every headline in the period counts equally.
Headlines on Thursday, October 29, 2026
1 headline, average tone +99: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.finanznachrichten.de · 1 outletNovocure Reports Third Quarter 2026 Financial Results and Raises 2026 GuidancePositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novocure Reports Third Quarter 2026 Financial Results and Raises 2026 Guidance | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Wednesday, October 28, 2026
1 headline, average tone +96: 1 positive, 0 neutral and 0 negative. Showing all 1.
- www.finanznachrichten.de · 1 outletNovocure to Evaluate Tumor Treating Fields Therapy with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, to Treat Pancreatic Cancer Through Clinical Trial Collaboration and Supply AgreementPositive
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Novocure to Evaluate Tumor Treating Fields Therapy with VS-7375, an Oral KRAS G12D (ON/OFF) Inhibitor, to Treat Pancreatic Cancer Through Clinical Trial Collaboration and Supply Agreement | www.finanznachrichten.de | 1 | Positive |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 15, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.tickerreport.com · 1 outletReviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR)Neutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Reviewing NeurAxis (NASDAQ:NRXS) & NovoCure (NASDAQ:NVCR) | www.tickerreport.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Friday, October 9, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.themarketsdaily.com · 1 outletNovoCure (NASDAQ:NVCR) and Medline (NASDAQ:MDLN) Financial AnalysisNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| NovoCure (NASDAQ:NVCR) and Medline (NASDAQ:MDLN) Financial Analysis | www.themarketsdaily.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
Headlines on Thursday, October 8, 2026
1 headline, average tone 0: 0 positive, 1 neutral and 0 negative. Showing all 1.
- www.dailypolitical.com · 1 outletNovoCure (NASDAQ:NVCR) versus Kewaunee Scientific (NASDAQ:KEQU) Head-To-Head ReviewNeutral
Show the table · 1 row, 4 columns
Scroll sideways to compare all columns. Select a heading to sort.
| NovoCure (NASDAQ:NVCR) versus Kewaunee Scientific (NASDAQ:KEQU) Head-To-Head Review | www.dailypolitical.com | 1 | Neutral |
No matching rows. Clear the filter to see all records.
How the score works
A headline's tone is not a forecast of the share price. Read the headlines themselves before acting on an average.
Which headlines count
Headlines come from the GDELT global news feed from 2019-09-23 on. A headline counts only when a model judges it to be about NovoCure Limited Ordinary Shares, not a passing mention.
How each headline is scored
The model calls each headline positive, neutral or negative news for the company. A period's tone is the share of positive minus negative headlines, from -100 (all negative) to +100 (all positive).
When a headline counts
Headlines published by 9:15 a.m. New York time belong to that day's session. Later and weekend headlines move to the next trading session.
Repeated stories
When several outlets carry the same headline, it counts once per session.